These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19427586)

  • 1. Identification, Ki determination and CoMFA analysis of nuclear receptor ligands as competitive inhibitors of OATP1B1-mediated estradiol-17beta-glucuronide transport.
    Gui C; Wahlgren B; Lushington GH; Hagenbuch B
    Pharmacol Res; 2009 Jul; 60(1):50-6. PubMed ID: 19427586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3.
    Gui C; Miao Y; Thompson L; Wahlgren B; Mock M; Stieger B; Hagenbuch B
    Eur J Pharmacol; 2008 Apr; 584(1):57-65. PubMed ID: 18321482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of modulators of the liver-specific organic anion-transporting polypeptides (OATPs) 1B1 and 1B3 from Rollinia emarginata Schlecht (Annonaceae).
    Roth M; Araya JJ; Timmermann BN; Hagenbuch B
    J Pharmacol Exp Ther; 2011 Nov; 339(2):624-32. PubMed ID: 21846839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further characterization of the electrogenicity and pH sensitivity of the human organic anion-transporting polypeptides OATP1B1 and OATP1B3.
    Martinez-Becerra P; Briz O; Romero MR; Macias RI; Perez MJ; Sancho-Mateo C; Lostao MP; Fernandez-Abalos JM; Marin JJ
    Mol Pharmacol; 2011 Mar; 79(3):596-607. PubMed ID: 21173039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3.
    Gozalpour E; Greupink R; Wortelboer HM; Bilos A; Schreurs M; Russel FG; Koenderink JB
    Mol Pharm; 2014 Jun; 11(6):1844-55. PubMed ID: 24754247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Octreotide inhibits the bilirubin carriers organic anion transporting polypeptides 1B1 and 1B3 and the multidrug resistance-associated protein 2.
    Visentin M; Stieger B; Merz M; Kullak-Ublick GA
    J Pharmacol Exp Ther; 2015 Nov; 355(2):145-51. PubMed ID: 26330539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the impact of substrate selection on in vitro organic anion transporting polypeptide 1B1 inhibition profiles for the prediction of drug-drug interactions.
    Izumi S; Nozaki Y; Maeda K; Komori T; Takenaka O; Kusuhara H; Sugiyama Y
    Drug Metab Dispos; 2015 Feb; 43(2):235-47. PubMed ID: 25414411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of porphyrins with human organic anion transporting polypeptide 1B1.
    Campbell SD; Lau WF; Xu JJ
    Chem Biol Interact; 2009 Nov; 182(1):45-51. PubMed ID: 19560444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of green tea catechins with organic anion-transporting polypeptides.
    Roth M; Timmermann BN; Hagenbuch B
    Drug Metab Dispos; 2011 May; 39(5):920-6. PubMed ID: 21278283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence-based assays for the assessment of drug interaction with the human transporters OATP1B1 and OATP1B3.
    Bednarczyk D
    Anal Biochem; 2010 Oct; 405(1):50-8. PubMed ID: 20540932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The eighth and ninth transmembrane domains in organic anion transporting polypeptide 1B1 affect the transport kinetics of estrone-3-sulfate and estradiol-17beta-D-glucuronide.
    Miyagawa M; Maeda K; Aoyama A; Sugiyama Y
    J Pharmacol Exp Ther; 2009 May; 329(2):551-7. PubMed ID: 19244099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate-dependent inhibition of organic anion transporting polypeptide 1B1: comparative analysis with prototypical probe substrates estradiol-17β-glucuronide, estrone-3-sulfate, and sulfobromophthalein.
    Izumi S; Nozaki Y; Komori T; Maeda K; Takenaka O; Kusano K; Yoshimura T; Kusuhara H; Sugiyama Y
    Drug Metab Dispos; 2013 Oct; 41(10):1859-66. PubMed ID: 23920221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3.
    Noé J; Portmann R; Brun ME; Funk C
    Drug Metab Dispos; 2007 Aug; 35(8):1308-14. PubMed ID: 17470528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-drug interactions between rosuvastatin and oral antidiabetic drugs occurring at the level of OATP1B1.
    van de Steeg E; Greupink R; Schreurs M; Nooijen IH; Verhoeckx KC; Hanemaaijer R; Ripken D; Monshouwer M; Vlaming ML; DeGroot J; Verwei M; Russel FG; Huisman MT; Wortelboer HM
    Drug Metab Dispos; 2013 Mar; 41(3):592-601. PubMed ID: 23248200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-drug interaction between pitavastatin and various drugs via OATP1B1.
    Hirano M; Maeda K; Shitara Y; Sugiyama Y
    Drug Metab Dispos; 2006 Jul; 34(7):1229-36. PubMed ID: 16595711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of OATP1B1/3 and OCT1 inhibitors in cryopreserved hepatocytes in suspension.
    Badolo L; Rasmussen LM; Hansen HR; Sveigaard C
    Eur J Pharm Sci; 2010 Jul; 40(4):282-8. PubMed ID: 20381614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organic anion transporting polypeptide (OATP)-mediated transport of coproporphyrins I and III.
    Bednarczyk D; Boiselle C
    Xenobiotica; 2016; 46(5):457-66. PubMed ID: 26383540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based identification of OATP1B1/3 inhibitors.
    De Bruyn T; van Westen GJ; Ijzerman AP; Stieger B; de Witte P; Augustijns PF; Annaert PP
    Mol Pharmacol; 2013 Jun; 83(6):1257-67. PubMed ID: 23571415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of polybrominated diphenyl ether uptake into the liver: PBDE congeners are substrates of human hepatic OATP transporters.
    Pacyniak E; Roth M; Hagenbuch B; Guo GL
    Toxicol Sci; 2010 Jun; 115(2):344-53. PubMed ID: 20176623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bosentan is a substrate of human OATP1B1 and OATP1B3: inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafil.
    Treiber A; Schneiter R; Häusler S; Stieger B
    Drug Metab Dispos; 2007 Aug; 35(8):1400-7. PubMed ID: 17496208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.